Exoskeleton Market Share, Emerging Trends and Overview to 2025: Hexa Reports

Hexa Reports

Market Research Reports and Insightful Company Profiles

Exoskeleton Market Analysis, Share and Size, Emerging

Trends, Growth, Overview And Segment Forecasts To 2025

The global exoskeleton market is expected to reach USD 3.3 billion by 2025, according to a new report

published by Grand View Research. Key factors driving the market expansion include the increasing

number of U.S. FDA products, growing demand for exoskeletons in rehabilitation, assisted walking,

military applications, and industrial applications.

The market is evolving rapidly due to the increasing adoption of exoskeleton technology in the

developed regions. The growing geriatric population coupled with increasing number of people suffering

with paraplegia, tetraplegia, and other spinal cord injuries are major factors boosting the usage rates of

exoskeletons.

Browse Detail Report With TOC @ http://www.hexareports.com/report/exoskeleton-market/details

The exoskeleton market has gained high momentum after the launch of products such as ReWalk bionic

suit, Ekso GT exoskeleton. Moreover, with the U.S. FDA approving the Parker Indego, commercialization

of exoskeleton devices is expected to increase significantly over the next few years.

In the U.S., the Defense Advanced Research Projects Agency (DARPA), National Aeronautics and Space

Administration (NASA), and National Institute of Health (NIH) have significantly contributed toward

technology development, research funding, and commercialization of these devices.

For instance, in 2014, Ekso Bionics received a P20 Exploratory Grant from the NIH to continue the

development of an exoskeleton prototype for children.

Hexa Reports

Market Research Reports and Insightful Company Profiles

In October, 2015, Parker Hannifin Corporation announced that it had agreed to supply Indego

exoskeleton for a 4-year multicenter study for the Department of Defense, which was funded by the U.S.

Department of Defense and the Congressionally Directed Medical Research...